NCT00376519: Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases |
|
|
| Terminated | 1 | 3 | US | cyclophosphamide, Cytoxan, cyclosporine, CSA, fludarabine phosphate, Fludara, mycophenolate mofetil, MMF, Treg cell infusion, umbilical cord blood transplantation, UCBT, total-body irradiation | Masonic Cancer Center, University of Minnesota | Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Secondary Myelofibrosis | 03/08 | 03/08 | | |
NCT00080925: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies |
|
|
| Completed | 1 | 20 | US | filgrastim, graft-versus-tumor induction therapy, rituximab, therapeutic allogeneic lymphocytes, cyclophosphamide, cyclosporine, cytarabine, doxorubicin hydrochloride, etoposide, fludarabine phosphate, prednisone, vincristine sulfate, peripheral blood stem cell transplantation | National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | | 12/10 | | |